Evidence map›Paper›PMID 25275464›Full record

ArticlePloS one2014

Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents.

Jennie Johnstone, Robin Parsons, Fernando Botelho, Jamie Millar, Shelly McNeil, Tamas Fulop, Janet McElhaney, Melissa K Andrew, Stephen D Walter, P J Devereaux and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04412265 (Relationship Between Frailty and Clinical Outcomes in Elderly Patients With COVID-19), which is not on this map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04412265 completednot on this mapstarted 2020, after this paper: background citation

Relationship Between Frailty and Clinical Outcomes in Elderly Patients With COVID-19

TypeobservationalSponsorUniversity of Milano BicoccaRan2020 to 2021Enrolled1,344ConditionsCovid19ArmsRelation between frailty and clinical outcomes in elderly patients with COVID-19.
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Rethinking immune studies: population-level immune variations and the path forward.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals.Journal of the American Geriatrics Society · 2021
    Trial
  5. Review
  6. The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  7. Article
  8. Article
  9. Organic Electrochemical Transistors for Biomarker Detections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  10. Article
  11. Article
  12. Cellular Senescence in Immunity against Infections.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Viral coinfections in COVID-19.Journal of medical virology · 2021
    Review
  17. Observational
  18. Immunotherapy for COVID-19: Evolving treatment of viral infection and associated adverse immunological reactions.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Jennie JohnstoneDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Robin ParsonsMcMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Fernando BotelhoMcMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Jamie MillarMcMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Shelly McNeilCanadian Center for Vaccinology, IWK Health Centre and Capital Health, Dalhousie University, Halifax, Nova Scotia, Canada.
Tamas FulopDepartment of Medicine, Geriatrics Division, Research Center on Aging, University of Sherbrooke, Sherbrooke, Quebec, Canada.
Janet McElhaneyDepartment of Medicine, Northern Ontario School of Medicine, Sudbury, Ontario, Canada.
Melissa K AndrewDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Stephen D WalterDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
P J DevereauxDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Mehrnoush MalekesmaeiliTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Ryan R BrinkmanTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
James MahonyDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Jonathan BramsonMcMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Mark LoebDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
McMaster University · CAMcMaster University Medical Centre · CADalhousie University · CABC Cancer Agency · CANOSM University · CAUniversité de Sherbrooke · CA

Funding

The Statistical and Computational Analysis of Flow Cytometry DataR01EB008400 · NIBIB · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GOTTARDO, RAPHAEL · 2008 to 2015
$2.9M
CIHRNIBIB NIH HHS R01 EB008400NIBIB NIH HHS R01 EB008400/EB/NIBIB
6 · The paper itself

Abstract

objectiveTo determine if immune phenotypes associated with immunosenescence predict risk of respiratory viral infection in elderly nursing home residents.

methodsResidents ≥ 65 years from 32 nursing homes in 4 Canadian cities were enrolled in Fall 2009, 2010 and 2011, and followed for one influenza season. Following influenza vaccination, peripheral blood mononuclear cells (PBMCs) were obtained and analysed by flow cytometry for T-regs, CD4+ and CD8+ T-cell subsets (CCR7+CD45RA+, CCR7-CD45RA+ and CD28-CD57+) and CMV-reactive CD4+ and CD8+ T-cells. Nasopharyngeal swabs were obtained and tested for viruses in symptomatic residents. A Cox proportional hazards model adjusted for age, sex and frailty, determined the relationship between immune phenotypes and time to viral infection.

results1072 residents were enrolled; median age 86 years and 72% female. 269 swabs were obtained, 87 were positive for virus: influenza (24%), RSV (14%), coronavirus (32%), rhinovirus (17%), human metapneumovirus (9%) and parainfluenza (5%). In multivariable analysis, high T-reg% (HR 0.41, 95% CI 0.20-0.81) and high CMV-reactive CD4+ T-cell% (HR 1.69, 95% CI 1.03-2.78) were predictive of respiratory viral infection.

conclusionsIn elderly nursing home residents, high CMV-reactive CD4+ T-cells were associated with an increased risk and high T-regs were associated with a reduced risk of respiratory viral infection.

Indexed as

Nursing HomesAgedAged, 80 and overBiomarkersCanadaCohort StudiesCytomegalovirusCytomegalovirus InfectionsFemaleHumansMaleMultivariate AnalysisPhenotypeRespiratory Tract InfectionsTime FactorsT-LymphocytesBiomarkers

Identifiers

PMID25275464
PMCPMC4183538
OpenAlexW2068926270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.